Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
     L04A IMMUNOSUPPRESSANTS
       L04AA Selective immunosuppressants
       L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors [DG:DG01936]
       L04AC Interleukin inhibitors [DG:DG02019]
       L04AD Calcineurin inhibitors [DG:DG03129]
         L04AD01 Ciclosporin
         L04AD02 Tacrolimus [DG:DG00439]
           D08556  Tacrolimus (INN)
           D00107  Tacrolimus (USP/INN) <JP/US>
         L04AD03 Voclosporin
       L04AE Sphingosine-1-phosphate (S1P) receptor modulators
       L04AF Janus-associated kinase (JAK) inhibitors
       L04AG Monoclonal antibodies
       L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors
       L04AJ Complement inhibitors
       L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors
       L04AL Neonatal fragment crystallizable receptor (FcRn) inhibitors
       L04AX Other immunosuppressants
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: January 6, 2026
According to WHO's ATC 2026

» Japanese version